1. Extended pharmacological thromboprophylaxis and clinically relevant venous thromboembolism after major abdominal and pelvic surgery : international, prospective, propensity score-weighted cohort study2025, izvirni znanstveni članek Ključne besede: anticoagulants, hemorrhage, cancer, surgical procedures, pharmacology, pelvis surgery, thromboprophylaxis, venous thromboembolism Objavljeno v DiRROS: 10.04.2026; Ogledov: 174; Prenosov: 114
Celotno besedilo (654,92 KB) Gradivo ima več datotek! Več... |
2. 30-day morbidity and mortality after cholecystectomy for benign gallbladder disease (AMBROSE) : a prospective, international collaborative cohort studyGeoffrey Yuet Mun Wong, Himanshu Wadhawan, Victor Roth Cardoso, Laura Bravo Merodio, Yashasvi Rajeev, Ricardo David Maldonado, Alessandro Martinino, Vignesh Balasubaramaniam, Ashraf Aabid, Adeela Siddiqui, 2025, izvirni znanstveni članek Ključne besede: benign gallbladder disease, cholecystectomy, morbidity, mortality Objavljeno v DiRROS: 09.04.2026; Ogledov: 133; Prenosov: 63
Celotno besedilo (218,07 KB) |
3. |
4. Safety of simultaneous robot-assisted resection of colorectal malignancy and synchronous liver metastasesMiha Petrič, Boštjan Plešnik, Jurij Aleš Košir, Blaž Trotovšek, Jan Grosek, 2026, izvirni znanstveni članek Povzetek: Introduction: Simultaneous resection of primary colorectal malignancies and liver metastases resulted in outcomes comparable to those achieved through a two-stage procedure, while offering the advantage of a single surgical intervention. The role of the robotic approach remains underexplored because of the lack of comprehensive evidence. The objective of our study was to examine the safety of the robotic surgical platform, assess its short-term outcomes, and compare them with those of open procedures. Methods and Material: We retrospectively analyzed data from an initial small series of eight consecutive patients treated at the UMC Ljubljana between March 2023 and December 2025. These patients underwent robot-assisted simultaneous resection of colorectal malignancies and liver metastases. Their outcomes were compared with those of an open cohort of eight patients. Results: The median operative time was 334 min (range, 193–415 min). No conversions or transfusions were required. Three patients experienced severe complications, accounting for 37.5% of the cohort. The median duration of hospitalization was 9.5 days. The median number of lymph nodes retrieved was 22. Complete (R0) resection of the primary tumor was achieved in all cases (100%), whereas resection of the liver was achieved in 87.5% of the cases. Importantly, there were no instances of re-hospitalization within 30 days or mortality within 90 days. Conclusions: Although the rate of severe complications is relatively high, the robotic surgical platform allows for the safe simultaneous resection of colorectal malignancies and liver metastases, achieving short-term outcomes comparable to those of open surgery. Ključne besede: simultaneous resection, colorectal malignancy, liver metastases, minimally invasive surgery Objavljeno v DiRROS: 01.04.2026; Ogledov: 184; Prenosov: 114
Celotno besedilo (402,57 KB) Gradivo ima več datotek! Več... |
5. Robotic right hemicolectomy for persistent colocutaneous fistula following laparoscopic appendectomy : a case reportAna Kalamutova, Jurij Aleš Košir, Jurij Janež, Jan Grosek, 2025, drugi znanstveni članki Povzetek: The article presents a case report of a patient who was referred to our hospital after laparoscopic appendectomy with severalrevisions, resulting in a persistent colocutaneous fistula to the hepatic flexure. After preoperative planning, a robotic righthemicolectomy was performed. The patient was discharged on postoperative day 7 with no postoperative complications.We concluded that robot-assisted colectomy after preoperative patient management can be performed as an effectivetechnique for colocutaneous fistula treatment with the benefits of minimal invasive surgery, including reduced postoperativepain, early patient mobilization, and shorter hospital stay Ključne besede: colocutaneous fistula, robotic surgery, colorectal surgery, robotic colectomy Objavljeno v DiRROS: 10.03.2026; Ogledov: 242; Prenosov: 209
Celotno besedilo (1,19 MB) Gradivo ima več datotek! Več... |
6. |
7. Colorectal-vaginal fistula after rectal cancer resection : international comparative cohort study of characteristics and treatmentMila L. Van Lieshout, Jobbe M. G. Lemmens, Nynke G. Greijdanus, Kiedo Wienholts, 2025, izvirni znanstveni članek Povzetek: A colorectal-vaginal fistula (CRVF) can occur as a complication of rectal cancer surgery. They can cause discomfort, repeated infection, need for treatment/further surgery, and a permanent stoma (an opening in the abdomen to collect bowel contents). This study looked at how often CRVF happened after surgery complicated by a leak where bowels ends have been joined together, how they were treated, and how likely patients were to live without a stoma 1 year after surgery. Researchers collected data on women from around the world who had rectal cancer surgery between 2014 and 2018 and developed a bowel leak (called anastomotic leakage). They compared those with and without a CRVF. A total of 88 out of 694 patients (12.7%) developed a CRVF. These patients more often had major surgery involving removal of nearby organs, including part of the vagina. They were more likely to have ongoing problems and needed more surgeries to manage them. Most had a temporary stoma, but only 29.5% could live without it after 1 year, compared with 48.7% of women without CRVF. CRVF is a serious complication that makes recovery harder. These patients are less likely to live without a stoma and usually need more surgery. However, if the leak is small, the chances of recovery without a permanent stoma are better. Ključne besede: rectal fistula, rectal cancer, rectal resections, postoperative complications, anastomotic leak Objavljeno v DiRROS: 05.01.2026; Ogledov: 551; Prenosov: 253
Celotno besedilo (339,42 KB) Gradivo ima več datotek! Več... |
8. Stomach cancer elective surgery morbidity and mortality at 90-Day (Hold Study) : a prospective, international collaborative cohort studyClaudia Neves-Marques, Mohamed Abulazayem, Geoffrey Yuet Mun Wong, Ricardo David Maldonado, Yirupaiahgari Viswanath, Jan Grosek, Jurij Aleš Košir, 2026, izvirni znanstveni članek Povzetek: Background: Data on multinational 90-day mortality and morbidity rates after surgery for gastric cancer is limited in the literature. This study aimed to understand the 90-day mortality and morbidity outcomes among patients undergoing elective gastric cancer surgery, as in the GASTRODATA Registry, and to identify associated risk factors. Methods: We conducted an international prospective study on patients aged ≥ 18 years undergoing elective surgery for gastric cancer with curative intent from January 4 to September 30, 2022. Known metastatic disease, concurrent secondary cancers, gastrointestinal stromal tumour (GIST) and Siewert type I/II oesophagogastric junction malignancies were excluded. Univariate and multivariate logistic regression were used to identify variables associated with the 90-day outcome. Results: 380 collaborators from 47 countries submitted data on 1538 patients. Median age was 65 years (IQR: 19–94), and 58.5% were males. 90-day morbidity and mortality rates were 38.2% (n = 587) and 2.9% (n = 45), respectively. Pre-operative higher Charlson Comorbidity Index, higher ASA score, pre-operative weight loss > 10%, positive specimen margin, and post-operative pathological IV staging (p value < 0.05) were significantly associated with clinically relevant complications and mortality. Conclusion: Elective gastric cancer surgery has a 90-day morbidity of 38.2% and a 90-day mortality of 2.9% globally. This study provided the most comprehensive international 90-day prospective data to date regarding gastric cancer surgery. Several factors associated with higher morbidity were identified, highlighting the importance of a unified language on surgical morbidity, prehabilitation, and ongoing audits to enhance patient outcomes. Ključne besede: gastric cancer, elective surgery, morbidity, mortality, 90-day postoperative outcomes, multinational audit, surgical complications, anastomotic leaks, patient safety Objavljeno v DiRROS: 16.12.2025; Ogledov: 1730; Prenosov: 210
Celotno besedilo (1,34 MB) Gradivo ima več datotek! Več... |
9. |
10. |